Raymond James & Associates’s Barings Corporate Investors MCI Stock Holding History
Bought
Maintained
Sold
Other funds holding MCI
BIA
CFMC
B
SIG
SAM
TCMG
CSC
Raymond James & Associates's MCI Position: Q3 2024 in Review
Raymond James & Associates reduced its Barings Corporate Investors (MCI) stake by 9% in Q3 2024, selling an estimated $38.3K and leaving 20,848 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #3212.
Raymond James & Associates first reported a position in MCI in Q4 2016 and has held it in 31 quarters since. The position peaked at $1.65M in Q2 2020. 55 funds tracked by Wall St. Rank hold MCI as of Q3 2024.
- Raymond James & Associates held 20,848 shares of Barings Corporate Investors worth $415K as of Q3 2024.
- Raymond James & Associates sold 2,069 Barings Corporate Investors shares in Q3 2024, an estimated $38.3K.
- Barings Corporate Investors made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3212 holding.
- Raymond James & Associates first reported a position in Barings Corporate Investors in Q4 2016 and has held it in 31 quarters since.
- Raymond James & Associates's Barings Corporate Investors position peaked at $1.65M in Q2 2020.
- 55 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.